This ETF Hedges Against Rising Healthcare Costs
Why It Matters
The ETFs give investors a transparent, tradable tool to offset soaring medical costs, addressing a growing risk for both individual portfolios and institutional pension liabilities.
Key Takeaways
- •Milliman launches two ETFs to hedge rising healthcare costs.
- •MHIG aims to match healthcare inflation; MHIP seeks to outperform it.
- •Portfolios blend healthcare equities, US Treasuries, and gold assets.
- •Active management leverages Milliman’s health trend data and risk expertise.
- •Younger, risk‑tolerant investors may prefer MHIP; conservative choose MHIG.
Summary
Milliman has introduced two new exchange‑traded funds, MHIG and MHIP, on the NYSE designed to give investors a direct hedge against the accelerating cost of health care.
The ETFs combine Milliman’s two‑decade track record in health‑care analytics with its three‑decade financial‑risk‑management pedigree, managing over $240 billion in assets and $30 billion as an ETF sub‑advisor. Their active strategies allocate across health‑care equities, U.S. Treasury bonds and a gold component, using the firm’s proprietary Health Trend guidelines to target inflation‑linked returns.
According to the launch interview, MHIG seeks to match the pace of health‑care inflation, while MHIP aims to exceed it, making the latter suitable for younger, higher‑risk investors. The managers cited GLP‑1 drug growth as a concrete example of cost drivers informing portfolio construction.
By offering a market‑based hedge, the funds could attract advisors seeking to protect client portfolios from rising medical expenses, potentially expanding the niche of inflation‑linked ETFs and influencing how insurers and pension plans manage health‑care liabilities.
Comments
Want to join the conversation?
Loading comments...